Skip to main content
. 2021 Jan 25;13(2):351. doi: 10.3390/nu13020351

Table 1.

Selected variants in GIP and GLP1R and their association with T2DM risk and glucose metabolism.

Gene SNP Alleles Consequence Associated traits Population Author
GIPR rs1800437 G/C Missense variant No association with T2DM EPIC-Potsdam, Germany Nitz et al. [182]
No association with T2DM Egyptian Shalaby et al. [183]
rs2302382 C/A Splice region variant Allele A was associated with T2DM risk Egyptian Shalaby et al. [183]
rs10423928 T/A Intron variant Allele A was associated with decreased insulin level after OGTT and increased risk of T2DM GWAS meta-analysis Saxena et al. [184]
Allele A was associated with an increased risk of T2DM Chinese Hu et al. [185]
Allele A was associated with higher fasting proinsulin levels and a lower insulinogenic index White European and US cohort Ingelsson et al. [186]
rs8108269 T/G Intergenic variant No association with T2DM Japanese Matsuba et al. [187]
Allele G identified as a risk allele for T2DM susceptibility European, GWAS Morris et al. [188]
rs2334255 G/T 3′ UTR variant Polymorphism associated with T2DM and obesity various, GWAS Zhang et al. [167]
GLP1R rs3765467 G/A/C/T Missense variant Effect allele A was associated with decreased risk of T2DM, decreased glucose level and HbA1c in control subjects without diabetes East Asian Kwak et al. [189]
Allele G identified as a risk allele for T2DM susceptibility Japanese Suzuki et al. [178]
rs10305492 G/A Missense variant Allele A was associated with lower fasting glucose level and a lower risk of T2DM - Scott et al. [190]
Allele A was associated with lower fasting glucose and T2DM risk Various, GWAS Wessel et al. [191]
rs367543060 C/T Missense variant No association with T2DM Egyptian Shalaby et al. [183]
rs6923761 G/A/C Missense variant No association with fasting glucose Caucasian females (diabetic) De Luis et al. [159]
Allele A was associated with higher insulin and HOMA levels Morbidly obese patients De Luis et al. [161]

T2DM: type 2 diabetes mellitus; OGTT: oral glucose tolerance test; GWAS: genome-wide association study; HbA1c: glycated hemoglobin; HOMA: homeostatic model assessment.